Biomedicina predictiva e investigación traslacional de las enfermedades respiratorias, cardiovasculares y metabólicas
BIOPRE
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublications in collaboration with researchers from GlaxoSmithKline (United Kingdom) (1)
2022
-
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial
The Lancet. Respiratory medicine, Vol. 10, Núm. 5, pp. 435-446